A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors

NCT05830045 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Qilu Pharmaceutical Co., Ltd.